Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg H Tesch

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Clinical Science (London, England : 1979)|August 2, 2017
Diabetic nephropathy - is this an immune disorder?Greg H Tesch
Seminars in Nephrology|July 13, 2010
Macrophages and diabetic nephropathyGreg H Tesch
Nephrology (Carlton, Vic.)|October 2, 2010
Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspectiveGreg H Tesch
Nephrology (Carlton, Vic.)|November 13, 2007
Quantification of renal pathology by image analysisGopala K Rangan, Greg H Tesch
Frontiers in Pharmacology|June 15, 2017
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac FibrosisGreg H Tesch, Morag J Young
Nephrology (Carlton, Vic.)|May 15, 2007
Rodent models of streptozotocin-induced diabetic nephropathyGreg H Tesch, Terri J Allen
Biochemical and Biophysical Research Communications|December 18, 2007
c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injuryKyoichi Fukuda, Greg H Tesch, David J Nikolic-Paterson
Physiological Reports|September 20, 2019
Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injuryLifang Tian, David J Nikolic-Paterson, Greg H Tesch
Anatomical Record (Hoboken, N.J. : 2007)|January 24, 2020
Targeting apoptosis signal-regulating kinase 1 in acute and chronic kidney diseaseGreg H Tesch, Frank Y Ma, David J Nikolic-Paterson
American Journal of Physiology. Renal Physiology|May 27, 2016
ASK1: a new therapeutic target for kidney diseaseGreg H Tesch, Frank Y Ma, David J Nikolic-Paterson
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Clinical Science (London, England : 1979)|August 2, 2017
Diabetic nephropathy - is this an immune disorder?Greg H Tesch
Seminars in Nephrology|July 13, 2010
Macrophages and diabetic nephropathyGreg H Tesch
Nephrology (Carlton, Vic.)|October 2, 2010
Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspectiveGreg H Tesch
Nephrology (Carlton, Vic.)|November 13, 2007
Quantification of renal pathology by image analysisGopala K Rangan, Greg H Tesch
Frontiers in Pharmacology|June 15, 2017
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac FibrosisGreg H Tesch, Morag J Young
Nephrology (Carlton, Vic.)|May 15, 2007
Rodent models of streptozotocin-induced diabetic nephropathyGreg H Tesch, Terri J Allen
Biochemical and Biophysical Research Communications|December 18, 2007
c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injuryKyoichi Fukuda, Greg H Tesch, David J Nikolic-Paterson
Physiological Reports|September 20, 2019
Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injuryLifang Tian, David J Nikolic-Paterson, Greg H Tesch
Anatomical Record (Hoboken, N.J. : 2007)|January 24, 2020
Targeting apoptosis signal-regulating kinase 1 in acute and chronic kidney diseaseGreg H Tesch, Frank Y Ma, David J Nikolic-Paterson
American Journal of Physiology. Renal Physiology|May 27, 2016
ASK1: a new therapeutic target for kidney diseaseGreg H Tesch, Frank Y Ma, David J Nikolic-Paterson
Pageof 5